1. Home
  2. CMAX vs FRES Comparison

CMAX vs FRES Comparison

Compare CMAX & FRES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMAX
  • FRES
  • Stock Information
  • Founded
  • CMAX 2011
  • FRES 2010
  • Country
  • CMAX United States
  • FRES British Virgin Islands
  • Employees
  • CMAX N/A
  • FRES N/A
  • Industry
  • CMAX Computer Software: Prepackaged Software
  • FRES Medical Specialities
  • Sector
  • CMAX Technology
  • FRES Health Care
  • Exchange
  • CMAX Nasdaq
  • FRES Nasdaq
  • Market Cap
  • CMAX 8.3M
  • FRES 70.9M
  • IPO Year
  • CMAX N/A
  • FRES 2020
  • Fundamental
  • Price
  • CMAX $2.15
  • FRES $2.96
  • Analyst Decision
  • CMAX Hold
  • FRES
  • Analyst Count
  • CMAX 2
  • FRES 0
  • Target Price
  • CMAX $33.20
  • FRES N/A
  • AVG Volume (30 Days)
  • CMAX 944.2K
  • FRES 9.9K
  • Earning Date
  • CMAX 08-07-2024
  • FRES 07-23-2024
  • Dividend Yield
  • CMAX N/A
  • FRES N/A
  • EPS Growth
  • CMAX N/A
  • FRES N/A
  • EPS
  • CMAX N/A
  • FRES N/A
  • Revenue
  • CMAX $810,364,000.00
  • FRES $2,345,304.00
  • Revenue This Year
  • CMAX $21.67
  • FRES N/A
  • Revenue Next Year
  • CMAX $1.21
  • FRES N/A
  • P/E Ratio
  • CMAX N/A
  • FRES N/A
  • Revenue Growth
  • CMAX 21.46
  • FRES N/A
  • 52 Week Low
  • CMAX $1.88
  • FRES $2.50
  • 52 Week High
  • CMAX $99.90
  • FRES $41.80
  • Technical
  • Relative Strength Index (RSI)
  • CMAX 43.11
  • FRES 40.27
  • Support Level
  • CMAX $2.00
  • FRES $2.81
  • Resistance Level
  • CMAX $2.51
  • FRES $3.70
  • Average True Range (ATR)
  • CMAX 0.71
  • FRES 0.40
  • MACD
  • CMAX -0.03
  • FRES 0.00
  • Stochastic Oscillator
  • CMAX 9.18
  • FRES 35.94

About CMAX CareMax Inc.

CareMax Inc is a technology-enabled care platform providing value-based care and chronic disease management to seniors. It operates various owned medical centers that offer a comprehensive suite of healthcare and social services and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.

About FRES Fresh2 Group Limited

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

Share on Social Networks: